VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

ARCH Venture Management, LLC's Holding History (CIK: 0001274403)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 2,008,809 Value ($000) $22,559 Avg Close — Range —
Q1 2025
Shares 2,008,809 Value ($000) $9,120 Avg Close — Range —
Q4 2024
Shares 2,008,809 Value ($000) $11,330 Avg Close — Range —
Q3 2024
Shares 2,008,809 Value ($000) $9,723 Avg Close — Range —
Q2 2024
Shares 2,008,809 Value ($000) $9,803 Avg Close — Range —
Q1 2024
Shares 2,008,809 Value ($000) $26,677 Avg Close — Range —
Q4 2023
Shares 2,008,809 Value ($000) $28,003 Avg Close — Range —
Q3 2023
Shares 2,008,809 Value ($000) $26,637 Avg Close — Range —
Q2 2023
Shares 2,008,809 Value ($000) $37,665 Avg Close — Range —
Q1 2023
Shares 2,008,809 Value ($000) $28,967 Avg Close — Range —
Q4 2022
Shares 2,008,809 Value ($000) $38,870 Avg Close — Range —
Q3 2022
Shares 2,008,809 Value ($000) $69,003 Avg Close — Range —
Q2 2022
Shares 2,508,809 Value ($000) $38,335 Avg Close — Range —
Q1 2022
Shares 2,508,809 Value ($000) $57,251 Avg Close — Range —
Q4 2021
Shares 2,508,809 Value ($000) $92,500 Avg Close — Range —